Amgen Drug for Aggressive Type of Lung Cancer Wins Accelerated FDA Approval
A new drug called Imdelltra has been approved by the FDA for the treatment of small cell lung cancer. This aggressive type of cancer often relapses after chemotherapy, but Imdelltra offers a new treatment option. The drug is an immunotherapy that targets a protein abundant in small cell lung cancer cells. Clinical trial results showed…